The FDA’s 2023 decision to maintain the restrictions was unlawful under the Administrative Procedure Act, “by failing to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results